Gallagher Duncan - Insider Non-Derivative Transactions at Health Catalyst, Inc. (HCAT) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 1, 2024, Gallagher Duncan's relationship to Health Catalyst, Inc. (HCAT) is Director, and currently has 76,937 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other HCAT insiders.
Data Source: SEC.
Gallagher Duncan - Insider Non-Derivative Transactions of HCAT Common Stock
Gallagher Duncan - Insider Non-Derivative Transactions at HCAT
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 2, 2024 | Acquisition -- (Common Stock) | 2414 | 0 | 76937 |
| Jun 14, 2024 | Acquisition -- (Common Stock) | 20807 | 0 | 74523 |
| Jun 15, 2023 | Acquisition -- (Common Stock) | 5806 | 0 | 41211 |
| Jun 15, 2023 | Acquisition -- (Common Stock) | 12505 | 0 | 53716 |